Magnesium Sulfate and Nimesulide Have Synergistic Effects on Rescuing Brain Damage after Transient Focal Ischemia
- 1 May 2012
- journal article
- research article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 29 (7) , 1518-1529
Abstract
Magnesium sulfate and nimesulide are commonly used drugs with reported neuroprotective effects. Their combination as stroke treatment has the potential benefits of decreasing individual drug dosage and fewer adverse effects. This study evaluated their synergistic effects and compared a low-dose combination with individual drug alone and placebo. Sprague-Dawley rats underwent 90 min of focal ischemia with intraluminal suture occlusion of the middle cerebral artery followed by reperfusion. The rats were randomly assigned to receive one of the following treatments: placebo, magnesium sulfate (MgSO 4 ; 45 mg/kg) intravenously immediately after the induction of middle cerebral artery occlusion, nimesulide (6 mg/kg) intraperitoneally before reperfusion, and combined therapy. Three days after the ischemia-reperfusion insult, therapeutic outcome was assessed by 2,3,5-triphenyltetrazolium chloride staining and a 28-point neurological severity scoring system. Cyclooxygenase-2, prostaglandin E 2 , myeloperoxidase, and caspase-3 expression after treatment were evaluated using Western blot analyses and immunohistochemical staining, followed by immunoreactive cell analysis using tissue cytometry. Only the combination treatment group showed a significant decrease in infarction volume (10.93±6.54% versus 26.43±7.08%, p p 4 or nimesulide showed no significant neuroprotection. There was also significant suppression of cyclooxygenase-2, prostaglandin E 2 , myeloperoxidase, and caspase-3 expression in the combination treatment group, suggesting that the combination of the two drugs improved the neuroprotective effects of each individual drug. MgSO 4 and nimesulide have synergistic effects on ischemia-reperfusion insults. Their combination helps decrease drug dosage and adverse effects. Combined treatment strategies may help to combat stroke-induced brain damage in the future.Keywords
This publication has 49 references indexed in Scilit:
- Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-UJournal of Experimental Medicine, 2010
- Current Status of Neuroprotection for Cerebral IschemiaStroke, 2009
- Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidaseProceedings of the National Academy of Sciences, 2008
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- G-CSF rescues the memory impairment of animal models of Alzheimer's diseaseJournal of Experimental Medicine, 2007
- Prostaglandin E2 deteriorates N-methyl-d-aspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neuronsLife Sciences, 2006
- Activation of Cytokine Signaling through Leukemia Inhibitory Factor Receptor (LIFR)/gp130 Attenuates Ischemic Brain Injury in RatsJournal of Cerebral Blood Flow & Metabolism, 2005
- Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System IschemiaStroke, 2000
- Spontaneous Hyperthermia and its Mechanism in the Intraluminal Suture Middle Cerebral Artery Occlusion Model of RatsStroke, 1999
- Reduction of Ischemic Brain Injury by Topical Application of Glial Cell Line–Derived Neurotrophic Factor After Permanent Middle Cerebral Artery Occlusion in RatsStroke, 1998